ELOBP1

Across TCGA pan-cancer cohorts, ELOBP1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ELOBP1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher ELOBP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOBP1 expression acts as an unfavorable survival marker, although some lineages such as CESC and PRAD show a favorable association.

UVM, BRCA, and CESC are the cancer types where ELOBP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Quartile	All	0.280	0.687	<.001	62	view →
BRCA	DFS	Median	IV	0.296	0.775	<.001	40	view →
CESC	DFS	Quartile	III,IV	1.000	0.663	.012	26	view →
TGCT	OS	Tertile	All	0.938	1.000	.011	26	view →
BLCA	DFS	Median	IV	0.118	0.263	.007	21	view →
ACC	DFS	Tertile	All	0.558	0.906	.004	19	view →
KIRC	DFS	Median	All	0.732	0.859	.006	19	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
READ	OS	Median	IV	0.562	0.878	.020	11	view →
PRAD	OS	Median	All	0.950	0.760	<.001	10	view →
PCPG	DFS	Tertile	All	0.978	0.833	.013	8	view →
ESCA	DFS	Quartile	III,IV	0.226	0.463	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ELOBP1–UVM (OS)

Open the UVM breakdown →